✦ LIBER ✦

Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer

✍ Scribed by Johannes Meiler, Melanie Guyot, Sandra Hoffarth, Emmanuelle Wesarg, Yvonne Höhn, Frank Breitenbuecher, Martin Schuler

Book ID: 113043185
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 450 KB
Volume: 138
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-012-1220-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

94 The cytotoxic effects of 17-AAG, an i

94 The cytotoxic effects of 17-AAG, an inhibitor of Hsp90 are enhanced by combination with the PI-3-kinase inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines

✍ V. Papadimitrakopoulou; S. Angelaki; S. Lnu; E. Brown; G. Ayers 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Effects of the proteasome inhibitor bort

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

✍ Melinda M. Mortenson; Michael G. Schlieman; Subbulakshmi Virudachalam; Richard J 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 836 KB

Initial comparative study on the efficac

Initial comparative study on the efficacy of single agent gemcitabine versus combination gemcitabine and cisplatin in Filipino patients with advanced non-small cell lung cancer

✍ Gorospe, A; Cristal-Luna, G; Li, R; Garcia, J; Roces, L; Lola, C; Matunog, C; Ma 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Vindesine and cisplatin combination chem

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study

✍ Elliott, J.A; Ahmedzai, S; Hole, D; Dorward, A.J; Stevenson, R.D; Kaye, S.B; Ban 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 784 KB

A phase II study of the safety and effic

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

✍ Leena Gandhi; Matthew W. Harding; Marcus Neubauer; Corey J. Langer; Melvin Moore 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Survivin mRNA expression in blood as a p

Survivin mRNA expression in blood as a predictor of the response to EGFR-tyrosine kinase inhibitors and prognosis in patients with non-small cell lung cancer

✍ Shi, Wei-Lin; Li, Jian; Bao, Quan-Lei; Wu, Jian-Nong; Ge, Li-Ping; Zhu, Li-Rong; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 514 KB